I don't think you will be disappointed if you got in at these levels. Xperience is about to be approved by the FDA (can't see why this will not happen). Xperience is their surgical site disinfectant wash that does not need to be rinsed before closing. It continues to fight bacterial and other infections in the wound. I believe this is a game changer in surgery and particularly in the fight against surgical sight infections. COVID has just been a real hand break, with the cessation of elective surgeries. So, well done and welcome to the group.
Personally I think this is the perfect time to be loading up on NXS. Unfortunately I got ahead of myself pre-COVID and have a much higher average entry price, but I really believe in the various products. The key risk here is whether management are skilled enough to get the message across and drive sales growth.
Time will tell.
NXS Price at posting:
$1.19 Sentiment: Buy Disclosure: Held
